UK health technology assessment body advising on cost-effective care
The UK and US have finalized a medicines partnership allowing British drug exports to avoid US tariffs and increasing NHS drug spending. Critics warn it risks NHS funding and transparency, while supporters highlight potential benefits for patients and the UK economy. The deal's details remain partly secret, raising concerns about oversight.
Prime Minister Benjamin Netanyahu has disclosed that doctors found a tiny, early-stage malignant tumor during routine follow-up after 2024 prostate surgery and that targeted radiation therapy has removed it. He has said he delayed publishing the report by two months to avoid fuelling Iranian misinformation during recent clashes. Doctors at Hadassah Medical Center have reported imaging and blood tests showing no remaining disease.
A roundup of recent cancer breakthroughs highlights new immunotherapies, targeted drugs and surgical-sparing treatments. The Independent reports on Scolyer’s pioneering work and a landmark NICE decision; The Guardian covers durvalumab’s promise in bladder cancer; Business Insider UK and Reuters summarize ASCO findings on pancreatic and colon cancers, among others.